# A Randomized Controlled Trial to Assess the Effect of L-carnitine in Patients With Diabetic Peripheral Neuropathy to Relief Pain and Symptom Improvement

> **NCT04145245** · PHASE2 · UNKNOWN · sponsor: **Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh** · enrollment: 104 (estimated)

## Conditions studied

- Patient Compliance

## Interventions

- **DRUG:** Levocarnitine

## Key facts

- **NCT ID:** NCT04145245
- **Lead sponsor:** Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-04-17
- **Primary completion:** 2019-12-30
- **Final completion:** 2020-02-28
- **Target enrollment:** 104 (ESTIMATED)
- **Last updated:** 2019-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04145245

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04145245, "A Randomized Controlled Trial to Assess the Effect of L-carnitine in Patients With Diabetic Peripheral Neuropathy to Relief Pain and Symptom Improvement". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04145245. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*